174 related articles for article (PubMed ID: 20532560)
1. Cancer in cohort of HIV-infected population: prevalence and clinical characteristics.
Zhang YX; Gui XE; Zhong YH; Rong YP; Yan YJ
J Cancer Res Clin Oncol; 2011 Apr; 137(4):609-14. PubMed ID: 20532560
[TBL] [Abstract][Full Text] [Related]
2. Cancer risk in the Swiss HIV Cohort Study: associations with immunodeficiency, smoking, and highly active antiretroviral therapy.
Clifford GM; Polesel J; Rickenbach M; Dal Maso L; Keiser O; Kofler A; Rapiti E; Levi F; Jundt G; Fisch T; Bordoni A; De Weck D; Franceschi S;
J Natl Cancer Inst; 2005 Mar; 97(6):425-32. PubMed ID: 15770006
[TBL] [Abstract][Full Text] [Related]
3. Cancer risk in people infected with human immunodeficiency virus in the United States.
Engels EA; Biggar RJ; Hall HI; Cross H; Crutchfield A; Finch JL; Grigg R; Hylton T; Pawlish KS; McNeel TS; Goedert JJ
Int J Cancer; 2008 Jul; 123(1):187-94. PubMed ID: 18435450
[TBL] [Abstract][Full Text] [Related]
4. Cancer risk in HIV-infected people in the USA from 1996 to 2012: a population-based, registry-linkage study.
Hernández-Ramírez RU; Shiels MS; Dubrow R; Engels EA
Lancet HIV; 2017 Nov; 4(11):e495-e504. PubMed ID: 28803888
[TBL] [Abstract][Full Text] [Related]
5. The impact of highly active antiretroviral therapy on the incidence and outcomes of AIDS-defining cancers in Southern Alberta.
Gingues S; Gill MJ
HIV Med; 2006 Sep; 7(6):369-77. PubMed ID: 16903981
[TBL] [Abstract][Full Text] [Related]
6. Cancer Incidence Among Adults With HIV in a Population-Based Cohort in Korea.
Park B; Ahn KH; Choi Y; Kim JH; Seong H; Kim YJ; Choi JY; Song JY; Lee E; Jun YH; Yoon YK; Choi WS; Lee M; Seong J; Kim SW
JAMA Netw Open; 2022 Aug; 5(8):e2224897. PubMed ID: 35917123
[TBL] [Abstract][Full Text] [Related]
7. A prevalence of posttransplantation cancers compared with cancers in people with human immunodeficiency virus/acquired immunodeficiency syndrome after highly active antiretroviral therapy.
Srisawat N; Avihingsanon A; Praditpornsilpa K; Jiamjarasrangsi W; Eiam-Ong S; Avihingsanon Y
Transplant Proc; 2008 Oct; 40(8):2677-9. PubMed ID: 18929833
[TBL] [Abstract][Full Text] [Related]
8. Underestimation of relative risks by standardized incidence ratios for AIDS-related cancers.
Chaturvedi AK; Mbulaiteye SM; Engels EA
Ann Epidemiol; 2008 Mar; 18(3):230-4. PubMed ID: 18083545
[TBL] [Abstract][Full Text] [Related]
9. Immune deficiency and risk for malignancy among persons with AIDS.
Mbulaiteye SM; Biggar RJ; Goedert JJ; Engels EA
J Acquir Immune Defic Syndr; 2003 Apr; 32(5):527-33. PubMed ID: 12679705
[TBL] [Abstract][Full Text] [Related]
10. HIV-related malignancies: community-based study using linkage of cancer registry and HIV registry data.
Cooksley CD; Hwang LY; Waller DK; Ford CE
Int J STD AIDS; 1999 Dec; 10(12):795-802. PubMed ID: 10639060
[TBL] [Abstract][Full Text] [Related]
11. Excess cancers among HIV-infected people in the United States.
Robbins HA; Pfeiffer RM; Shiels MS; Li J; Hall HI; Engels EA
J Natl Cancer Inst; 2015 Apr; 107(4):. PubMed ID: 25663691
[TBL] [Abstract][Full Text] [Related]
12. Italian cancer figures, report 2013: Multiple tumours.
AIRTUM Working Group
Epidemiol Prev; 2013; 37(4-5 Suppl 1):1-152. PubMed ID: 24259384
[TBL] [Abstract][Full Text] [Related]
13. Cancer risk among participants in the women's interagency HIV study.
Hessol NA; Seaberg EC; Preston-Martin S; Massad LS; Sacks HS; Silver S; Melnick S; Abulafia O; Levine AM;
J Acquir Immune Defic Syndr; 2004 Aug; 36(4):978-85. PubMed ID: 15220706
[TBL] [Abstract][Full Text] [Related]
14. Highly active antiretroviral therapy and incidence of cancer in human immunodeficiency virus-infected adults.
International Collaboration on HIV and Cancer
J Natl Cancer Inst; 2000 Nov; 92(22):1823-30. PubMed ID: 11078759
[TBL] [Abstract][Full Text] [Related]
15. Characteristics of non-AIDS-defining malignancies in the HAART era: a clinico-epidemiological study.
Dauby N; De Wit S; Delforge M; Necsoi VC; Clumeck N
J Int AIDS Soc; 2011 Mar; 14():16. PubMed ID: 21443771
[TBL] [Abstract][Full Text] [Related]
16. Incidence of AIDS-defining cancers and virus-related and non-virus-related non-AIDS-defining cancers among HIV-infected patients compared with the general population in a large health district of Northern Italy, 1999-2009.
Calabresi A; Ferraresi A; Festa A; Scarcella C; Donato F; Vassallo F; Limina R; Castelli F; Quiros-Roldan E;
HIV Med; 2013 Sep; 14(8):481-90. PubMed ID: 23560682
[TBL] [Abstract][Full Text] [Related]
17. Burden of non-AIDS-defining and non-virus-related cancers among HIV-infected patients in the combined antiretroviral therapy era.
Albini L; Calabresi A; Gotti D; Ferraresi A; Festa A; Donato F; Magoni M; Castelli F; Quiros-Roldan E
AIDS Res Hum Retroviruses; 2013 Aug; 29(8):1097-104. PubMed ID: 23581483
[TBL] [Abstract][Full Text] [Related]
18. Effect of immunodeficiency, HIV viral load, and antiretroviral therapy on the risk of individual malignancies (FHDH-ANRS CO4): a prospective cohort study.
Guiguet M; Boué F; Cadranel J; Lang JM; Rosenthal E; Costagliola D;
Lancet Oncol; 2009 Dec; 10(12):1152-9. PubMed ID: 19818686
[TBL] [Abstract][Full Text] [Related]
19. HIV and cancer registry linkage identifies a substantial burden of cancers in persons with HIV in India.
Godbole SV; Nandy K; Gauniyal M; Nalawade P; Sane S; Koyande S; Toyama J; Hegde A; Virgo P; Bhatia K; Paranjape RS; Risbud AR; Mbulaiteye SM; Mitsuyasu RT
Medicine (Baltimore); 2016 Sep; 95(37):e4850. PubMed ID: 27631245
[TBL] [Abstract][Full Text] [Related]
20. Risk of human papillomavirus-associated cancers among persons with AIDS.
Chaturvedi AK; Madeleine MM; Biggar RJ; Engels EA
J Natl Cancer Inst; 2009 Aug; 101(16):1120-30. PubMed ID: 19648510
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]